Artificial Intelligence: An AI Algorithm Predicts Risk Of Pancreatic Cancer Occurring In 36 Months (Study)
The study was led by researchers at Harvard Medical School and the University of Copenhagen in collaboration with VA Boston Healthcare System, the Dana-Farber Cancer Institute and the Harvard T.H. Chan School of Public Health.
A recent study suggests that an AI tool can predict the risk of pancreatic cancer up to three years in advance by analyzing patients’ medical records. The study used an AI-based population screening method that helps identify a specific biomarker of certain diseases, which can be difficult to catch in the early stages.
The researchers applied an AI algorithm to clinical data from nine million patients from Denmark and the US, and trained the AI learning models to read diagnosis codes in the patient’s data and connect them to pancreatic cancer. The AI models were tested for potential diagnosis at different times and were substantially more accurate than current population-wide estimates of disease incidence. (Nature Medicine)
The study was published in the journal Nature Medicine and led by investigators at Harvard Medical School and the University of Copenhagen in collaboration with VA Boston Healthcare System, the Dana-Farber Cancer Institute and the Harvard T.H. Chan School of Public Health.
The early detection of pancreatic cancer is challenging as the cancer often does not show up on imaging tests, leading to a low five-year relative survival rate. Therefore, an AI tool that can identify those at high risk of the disease could go a long way towards improving clinical decision-making.
The study supervisor, Søren Brunak, a professor of disease systems biology at the University of Copenhagen, believes that AI-based screening is an opportunity to alter the trajectory of pancreatic cancer, an aggressive disease that is notoriously hard to diagnose early and treat promptly when the chances for success are highest.
However, the technology is still in its early stages and requires further testing.
The potential benefits of an AI tool that can identify those at high risk of pancreatic cancer include reducing healthcare costs and improving patient outcomes.
Related Story: Convergent Therapeutics Lands $90M For Treatment Of Cancers Using Radiopharmaceuticals
Image credit: Flickr
Latest Alternative Investment News
FinTech: Adyen Launches ‘Payout Services’ For Faster Payouts To The Gig And SMB Economies
Adyen, a global financial technology platform, has launched Payout Services, allowing its customers to make instant payouts to their users or partners. By connecting directly to real-time payment rails, Adyen’s…
Digital Assets: Oracle Red Bull Racing Seeks To Digitize Engagement With Fans On The Sui Blockchain
Oracle Red Bull Racing has announced a multi-year partnership with software company Mysten Labs to collaborate on Sui, which will serve as the team’s Official Blockchain partner. Sui, a Layer…
Venture Capital: Bold, L’Oréal’s Venture Capital Fund, Buys A Stake In Exotic Cosmetic Ingredient Maker Debut
L’Oréal’s (EPA: OR) corporate venture capital fund, BOLD, has announced a minority investment in Debut, a US biotech company specializing in the discovery, formulation, and manufacture of novel ingredients and…
Artificial Intelligence: In Flight Simulation, An AI Drone Tries To Kill Its Own Handler
During a simulated test at a London summit, an AI-controlled drone turned against its human operator, raising significant ethical concerns. Air Force Colonel Tucker “Cinco” Hamilton shared the incident, which…